Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Helena Hanna"'
Autor:
Mila Oiva, Ksenia Mukhina, Vejune Zemaityte, Andres Karjus, Mikhail Tamm, Tillmann Ohm, Mark Mets, Daniel Chávez Heras, Mar Canet Sola, Helena Hanna Juht, Maximilian Schich
Publikováno v:
Humanities & Social Sciences Communications, Vol 11, Iss 1, Pp 1-15 (2024)
Abstract Audiovisual news is a critical cultural phenomenon that has been influencing audience worldviews for more than a hundred years. To understand historical trends in multimodal audiovisual news, we need to explore them longitudinally using larg
Externí odkaz:
https://doaj.org/article/250117942369494cae69ec7b8577f957
Autor:
Gokce Deniz Ardor, Miglena K. Komforti, Helena Hanna, Onur Ibanoglu, Abigail Lochala, Aziza Nassar
Publikováno v:
The Breast Journal, Vol 2023 (2023)
Introduction. Recent trials demonstrated clinically significant benefits in HER2-nonamplified breast cancer with HER2-low expression using novel anti-HER2 antibody-drug conjugates. Thus, HER2-low breast cancer was proposed as a separate diagnostic en
Externí odkaz:
https://doaj.org/article/71bf1105ca614e7781e6c6a86d2204b4
Publikováno v:
Cancer Treatment and Research Communications, Vol 26, Iss , Pp 100306- (2021)
Background: Oncotype Dx® (ODX) is the most used prognostic and predictive assay for ER + breast cancer (BCa) and is categorized into low (< 18), intermediate (18 to 30), or high (≥31) risk of recurrence. Prosigna® is a prognostic signature to est
Externí odkaz:
https://doaj.org/article/cec070bcb39749a48660ef99656bcc30
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Surgery Case Reports. 103:107907
Autor:
Aadli, Helena Hanna Maija
dc.description.uri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1018::3914145d1dbc8ed1eedc7996a7ef57c7
http://hdl.handle.net/10062/75591
http://hdl.handle.net/10062/75591
Publikováno v:
Cancer Treatment and Research Communications, Vol 26, Iss, Pp 100306-(2021)
Background: Oncotype Dx® (ODX) is the most used prognostic and predictive assay for ER + breast cancer (BCa) and is categorized into low (< 18), intermediate (18 to 30), or high (≥31) risk of recurrence. Prosigna® is a prognostic signature to est
Autor:
Juht, Helena Hanna
Uurimistöö eesmärk oli uurida Tervise Arengu Instituudi kogutud andmete põhjal VEPA Käitumisoskuste Mängu mõju 7-8-aastaste laste (N = 330) pidurduslikule kontrollile. Mängus osalenud laste Go/No-Go testi tulemusi võrreldi kontrollgrupi tule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1018::166d06e4ff75464b65bb8eaa4a5610bb
http://hdl.handle.net/10062/75667
http://hdl.handle.net/10062/75667
Autor:
Adriana Aparecida Apolari Volpi, Alexia Cristina Bretanha Vasquez, Frederico Tadeu Deloroso, Helena Hanna Khalil Giusti
Publikováno v:
Fisioterapia Brasil. 11:70-77
O Fibro Edema Gelóide (FEG) pode ser definido como uma patologia multifatorial resultando em uma degeneração do tecido adiposo, passando por fases de alteração de matriz intersticial, estase microcirculatória e hipertrofia dos adipócitos, evol
Publikováno v:
Fisioterapia Brasil. 12:53-57
A lipoaspiração (LP) é indicada para remoção de gordura localizada de uma determinada área, onde não se obtém a redução da mesma num processo de emagrecimento; porém, podem acontecer alguns eventos clínicos como edema, hematomas, fibros